$5650 | Single User
$6650 | Multi User
$8150 | Corporate License
$10000 | Enterprise License

Electroceuticals/Bioelectric Medicine Market by Product (Pacemakers, Cochlear Implants, Spinal Cord Stimulators), Type of Device (Implantable, Non-Invasive), Application (Arrhythmia, Depression, Migraine), End User (Hospitals) - Global Forecast to 2021 [Report Updated: 06-06-2016]

Published by MarketsandMarkets: 06 Jun 2016 | 51136 | In Stock

Introduction

The global electroceuticals/bioelectric medicine market is expected to reach USD 25.20 billion by 2021 from USD 17.20 billion in 2016, growing at a CAGR of 7.9% from 2016 to 2021.

Electroceuticals are medical devices that use electrical impulses to modulate the body's neural circuits as an alternative to drug-based interventions. These electroceutical devices read and modify electrical signals passing along the nerves of the body, including irregular or altered impulses that can occur in association with a broad range of diseases.


The implantable cardioverter defibrillators segment is expected to account for the largest share of the electroceuticals/bioelectric medicine market, by product, in 2016. Increasing sudden cardiac arrest (SCA) leading to cardiovascular death, technological advancements in ICDs, and increasing arrhythmia is contributing to the large share of this segment. The implantable electroceutical devices segment is expected to account for the largest share of the electroceuticals/bioelectric medicine market, by type of device, in 2016. The rising research in this industry and collaborations and partnerships to development electroceutical devices, these devices providing continuous treatment within the body, and providing an environment for the easy treatment of patients is driving growth in this market segment. The hospitals segment is estimated to account for the largest share of the electroceuticals/bioelectric medicine market, by end user, in 2016. This can be attributed to increasing burden of diseases such as cardiac arrhythmias, Parkinson’s, Alzheimer’s, retinitis pigmentosa, epilepsy, and depression; and increasing awareness about electroceuticals.

North America is expected to account for the largest share of the global electroceuticals/bioelectric medicine market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of the North American region can be attributed to the rising prevalence of arrhythmia, growing prevalence of chronic diseases, expected approvals for retinal implants, increasing regulatory approvals in the U.S., increasing burden of cancer and diabetes, and increase in hearing loss owing to rising aging population in Canada, among others. The Asia-Pacific region is expected to witness the highest growth rate in the forecast period, mainly due to the rising adoption of neurostimulation, increasing cases of diabetes, increasing prevalence of hearing loss, increasing geriatric population, conferences on electroceutical devices, increasing prevalence of Parkinson’s Disease, and regulatory approvals of cochlear implants in the Asia-Pacific region.

The electroceuticals/bioelectric medicine market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (product launches, approvals, new product launches, agreements/collaborations/joint ventures/partnerships, marketing and promotion activities, acquisitions and mergers, expansions, market developments, new program launches, and product enhancements) to increase their market shares and establish a stronger foothold in the global market.

Medtronic plc (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Limited (Australia), Sonova Holding AG (Switzerland), LivaNova PLC (U.K.), Biotronik (Germany), Nevro Corporation (U.S.), Second Sight Medical Products, Inc. (U.S.), and ElectroCore LLC (U.S.) are the key players in the global electroceuticals/bioelectric medicine market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios of the top players in the medical animation market. The report analyzes the market based on product, type of device, application, and end user

• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the electroceuticals/bioelectric medicine market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various electroceuticals/bioelectric medicines across regions

• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the electroceuticals/bioelectric medicine market

• Competitive Assessment: In-depth assessment of strategies, products, distribution networks, and manufacturing capabilities of the leading players in the electroceuticals/bioelectric medicine market

Table of Contents
for Electroceuticals/Bioelectric Medicine Market by Product (Pacemakers, Cochlear Implants, Spinal Cord Stimulators), Type of Device (Implantable, Non-Invasive), Application (Arrhythmia, Depression, Migraine), End User (Hospitals) - Global Forecast to 2021 [Report Updated: 06-06-2016]

  • TABLE OF CONTENTS

    1 INTRODUCTION 20

    1.1 OBJECTIVES OF STUDY 20

    1.2 MARKET DEFINITION 20

    1.3 MARKET SCOPE 20

    1.3.1 MARKETS COVERED 21

    1.3.2 YEARS CONSIDERED FOR THE STUDY 22

    1.4 CURRENCY 22

    1.5 LIMITATIONS 22

    1.6 STAKEHOLDERS 23

    2 RESEARCH METHODOLOGY 24

    2.1 RESEARCH METHODOLOGY STEPS 24

    2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 25

    2.2.1 SECONDARY RESEARCH 25

    2.2.2 PRIMARY RESEARCH 26

    2.2.3 KEY INDUSTRY INSIGHTS 27

    2.3 KEY DATA FROM PRIMARY SOURCES 28

    2.4 KEY INSIGHTS FROM PRIMARY SOURCES 28

    2.5 MARKET SIZE ESTIMATION METHODOLOGY 29

    2.6 RESEARCH DESIGN 33

    2.7 MARKET DATA VALIDATION AND TRIANGULATION 34

    2.8 ASSUMPTIONS FOR THE STUDY 35

    3 EXECUTIVE SUMMARY 36

    3.1 INTRODUCTION 36

    3.2 CURRENT SCENARIO 37

    3.3 FUTURE OUTLOOK 38

    4 PREMIUM INSIGHTS 41

    4.1 GLOBAL ELECTROCEUTICALS MARKET 41

    4.2 GLOBAL ELECTROCEUTICALS MARKET, BY PRODUCT 42

    4.3 GLOBAL ELECTROCEUTICALS MARKET, BY REGION, AND DEEP BRAIN STIMULATION APPLICATIONS 43

    4.4 GLOBAL ELECTROCEUTICALS MARKET, BY REGION 44

    4.5 GLOBAL ELECTROCEUTICALS MARKET, BY END USER (2016 VS. 2021) 45

    5 MARKET OVERVIEW 46

    5.1 INTRODUCTION 47

    5.2 MARKET DYNAMICS 47

    5.2.1 DRIVERS 48

    5.2.1.1 Rising geriatric population 48

    5.2.1.2 Regulatory approvals for new and advanced electroceuticals 48

    5.2.1.3 Growing investments and funds for developing novel therapies and electroceuticals 49

    5.2.1.4 Rising prevalence of neurological disorders 50

    5.2.1.5 Growing prevalence of hearing loss 50

    5.2.2 RESTRAINTS 51

    5.2.2.1 Lack of skilled professionals 51

    5.2.2.2 High cost of cochlear implants 52

    5.2.3 OPPORTUNITIES 52

    5.2.3.1 Growth potential offered by emerging countries 52

    5.2.3.2 Strong product pipeline 53

    5.2.4 CHALLENGE 53

    5.2.4.1 Unfavorable reimbursement scenario 53

    6 GLOBAL ELECTROCEUTICALS MARKET, BY PRODUCT 55

    6.1 INTRODUCTION 56

    6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 59

    6.3 CARDIAC PACEMAKERS 60

    6.4 SPINAL CORD STIMULATORS 62

    6.5 COCHLEAR IMPLANTS 63

    6.6 DEEP BRAIN STIMULATORS 65

    6.7 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS 66

    6.8 VAGUS NERVE STIMULATORS 68

    6.9 SACRAL NERVE STIMULATORS 69

    6.10 RETINAL IMPLANTS 71

    6.11 OTHER ELECTRICAL STIMULATORS 73

    7 GLOBAL ELECTROCEUTICALS MARKET, BY TYPE OF DEVICE 75

    7.1 INTRODUCTION 76

    7.2 IMPLANTABLE ELECTROCEUTICAL DEVICES 78

    7.3 NON-INVASIVE ELECTROCEUTICAL DEVICES 79

    8 GLOBAL ELECTROCEUTICALS MARKET, BY APPLICATION 81

    8.1 INTRODUCTION 82

    8.2 CARDIAC PACEMAKERS AND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY APPLICATION 83

    8.2.1 ARRHYTHMIA 83

    8.3 SPINAL CORD STIMULATORS MARKET, BY APPLICATION 84

    8.3.1 CHRONIC PAIN 84

    8.3.2 FAILED BACK SYNDROME 86

    8.3.3 ISCHEMIA 87

    8.4 COCHLEAR IMPLANTS MARKET, BY APPLICATION 89

    8.4.1 SENSORINEURAL HEARING LOSS 89

    8.5 DEEP BRAIN STIMULATORS MARKET, BY APPLICATION 89

    8.5.1 PARKINSON’S DISEASE 90

    8.5.2 TREMOR 91

    8.5.3 DEPRESSION 93

    8.5.4 OTHER DEEP BRAIN STIMULATION APPLICATIONS 94

    8.6 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION 96

    8.6.1 TREATMENT-RESISTANT DEPRESSION 97

    8.6.2 OTHER TRANSCUTANEOUS ELECTRICAL STIMULATION APPLICATIONS 98

    8.7 VAGUS NERVE STIMULATORS MARKET, BY APPLICATION 100

    8.7.1 EPILEPSY 100

    8.7.2 OTHER VAGUS NERVE STIMULATION APPLICATIONS 102

    8.8 SACRAL NERVE STIMULATORS MARKET, BY APPLICATION 103

    8.8.1 URINARY INCONTINENCE 104

    8.8.2 FECAL INCONTINENCE 105

    8.9 RETINAL IMPLANTS MARKET, BY APPLICATION 107

    8.9.1 RETINITIS PIGMENTOSA 107

    8.10 OTHER ELECTRICAL STIMULATORS MARKET, BY APPLICATION 107

    8.10.1 GASTROPARESIS 108

    8.10.2 OBESITY 109

    8.10.3 DEPRESSION 111

    8.10.4 MIGRAINE 112

    8.10.5 SPINAL CORD INJURY 114

    9 GLOBAL ELECTROCEUTICALS MARKET, BY END USER 116

    9.1 INTRODUCTION 117

    9.2 HOSPITALS 119

    9.3 RESEARCH INSTITUTES 120

    9.4 INDIVIDUAL USERS 122

    10 GLOBAL ELECTROCEUTICALS MARKET, BY REGION 124

    10.1 INTRODUCTION 125

    10.2 NORTH AMERICA 127

    10.2.1 U.S. 133

    10.2.1.1 Rising prevalence of arrhythmia in the U.S. 133

    10.2.1.2 Rising prevalence of chronic diseases in U.S. 133

    10.2.1.3 High prevalence of hearing loss in U.S. 133

    10.2.1.4 Rising incidence of RP driving demand for retinal implants 134

    10.2.1.5 Conferences and annual meetings 134

    10.2.1.6 Increasing regulatory approvals in U.S. 134

    10.2.2 CANADA 139

    10.2.2.1 Growing burden of cancer and diabetes in Canada 139

    10.2.2.2 Increasing hearing loss due to rising aging population 139

    10.3 EUROPE 144

    10.3.1 RAPIDLY AGING POPULATION IN EUROPE 145

    10.3.2 CONFERENCES AND ANNUAL MEETINGS 145

    10.3.3 GOVERNMENT SUPPORT FOR HEARING IMPLANTS 146

    10.3.4 RISING PREVALENCE OF NEUROLOGICAL DISEASES IN GERMANY AND FRANCE 146

    10.3.5 RISING PREVALENCE OF DIABETES IN U.K. AND REST OF EUROPE 146

    10.3.6 INCREASING REGULATORY APPROVALS IN EUROPE 147

    10.4 ASIA-PACIFIC 151

    10.4.1 RISING AGING POPULATION DRIVING INCREASE IN DISEASE INCIDENCE IN JAPAN 152

    10.4.2 INCREASING PREVALENCE OF DIABETES AND RAPIDLY AGING POPULATION IN CHINA 152

    10.4.3 INCREASING PREVALENCE OF HEARING LOSS IN ASIA-PACIFIC 152

    10.4.4 INCREASING GERIATRIC POPULATION AND HIGH DIABETES PREVALENCE IN INDIA 153

    10.4.5 CONFERENCES ON ELECTROCEUTICAL DEVICES IN APAC 153

    10.4.6 INCREASING PREVALENCE OF PARKINSON’S DISEASE IN SINGAPORE 154

    10.5 REST OF WORLD 158

    10.5.1 RISE IN AGING POPULATION AND PREVALENCE OF DIABETES IN MIDDLE EAST AND AFRICA 159

    10.5.2 CONFERENCES ON ELECTROCEUTICAL DEVICES IN LATIN AMERICA AND AFRICA 159

    10.5.3 GROWING CASES OF CANCER IN LATIN AMERICA 159

    11 COMPETITIVE LANDSCAPE 164

    11.1 OVERVIEW 164

    11.2 COMPETITIVE SITUATION AND TRENDS 164

    11.2.1 INTRODUCTION 165

    11.2.2 PRODUCT LAUNCHES 165

    11.2.3 APPROVALS 166

    11.2.4 NEW PRODUCT LAUNCHES 167

    11.2.5 AGREEMENTS, COLLABORATIONS, JOINT VENTURES, AND PARTNERSHIPS 168

    11.2.6 MARKETING AND PROMOTION ACTIVITIES 169

    11.2.7 ACQUISITIONS AND MERGERS 170

    11.2.8 EXPANSIONS 170

    11.2.9 OTHER STRATEGIES 171

    11.3 GLOBAL ELECTROCEUTICALS MARKET: EMPIRICAL ASSESSMENT OF GROWTH STRATEGIES 172

    11.3.1 ROUTE TO STRATEGIC GROWTH: ORGANIC AND INORGANIC GROWTH STRATEGIES 172

    11.3.2 ORGANIC GROWTH STRATEGIES 173

    11.3.3 INORGANIC GROWTH STRATEGIES 174

    12 COMPANY PROFILES 175

    (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

    12.1 INTRODUCTION 175

    12.2 MEDTRONIC PLC 176

    12.3 ST. JUDE MEDICAL, INC. 180

    12.4 BOSTON SCIENTIFIC CORPORATION 183

    12.5 COCHLEAR LIMITED 186

    12.6 SONOVA HOLDING AG 188

    12.7 LIVANOVA PLC 190

    12.8 BIOTRONIK 194

    12.9 NEVRO CORPORATION 196

    12.10 SECOND SIGHT MEDICAL PRODUCTS, INC. 198

    12.11 ELECTROCORE LLC 200

    *Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

    13 APPENDIX 201

    13.1 DISCUSSION GUIDE 201

    13.2 COMPANY DEVELOPMENTS (2013–2016) 206

    13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 213

    13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 215

    13.5 AVAILABLE CUSTOMIZATIONS 216

    13.6 RELATED REPORTS 217

List Of Tables
in Electroceuticals/Bioelectric Medicine Market by Product (Pacemakers, Cochlear Implants, Spinal Cord Stimulators), Type of Device (Implantable, Non-Invasive), Application (Arrhythmia, Depression, Migraine), End User (Hospitals) - Global Forecast to 2021 [Report Updated: 06-06-2016]

LIST OF TABLES


TABLE 1 PREVALENCE OF HEARING LOSS, BY REGION, 2012 (IN MILLION) 50

TABLE 2 GROWING INVESTMENTS AND FUNDS FOR THE DEVELOPMENT OF NOVEL THERAPIES AND ELECTROCEUTICALS DRIVING MARKET GROWTH 51

TABLE 3 LACK OF SKILLED PROFESSIONALS RESTRAINING MARKET GROWTH 52

TABLE 4 EMERGING COUNTRIES TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES 53

TABLE 5 UNFAVORABLE REIMBURSEMENT SCENARIO IS A MAJOR CHALLENGE 54

TABLE 6 GLOBAL ELECTROCEUTICALS MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 57

TABLE 7 GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE,

BY REGION, 2014–2021 (USD MILLION) 59

TABLE 8 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 60

TABLE 9 GLOBAL CARDIAC PACEMAKERS MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 61

TABLE 10 NORTH AMERICA: CARDIAC PACEMAKERS MARKET SIZE, BY COUNTRY,

2014–2021 (USD MILLION) 61

TABLE 11 GLOBAL SPINAL CORD STIMULATORS MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 62

TABLE 12 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET SIZE,

BY COUNTRY, 2014–2021 (USD MILLION) 63

TABLE 13 GLOBAL COCHLEAR IMPLANT MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 64

TABLE 14 NORTH AMERICA: COCHLEAR IMPLANT MARKET SIZE, BY COUNTRY,

2014–2021 (USD MILLION) 64

TABLE 15 GLOBAL DEEP BRAIN STIMULATORS MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 65

TABLE 16 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET SIZE, BY COUNTRY,

2014–2021 (USD MILLION) 66

TABLE 17 GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET SIZE,

BY REGION, 2014–2021 (USD MILLION) 67

TABLE 18 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 67

TABLE 19 GLOBAL VAGUS NERVE STIMULATORS MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 68

TABLE 20 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 69

TABLE 21 GLOBAL SACRAL NERVE STIMULATORS MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 70

TABLE 22 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET SIZE,

BY COUNTRY, 2014–2021 (USD MILLION) 70

TABLE 23 GLOBAL RETINAL IMPLANTS MARKET SIZE, BY REGION,

2014–2021 (USD MILLION)* 72

TABLE 24 NORTH AMERICA: RETINAL IMPLANTS MARKET SIZE, BY COUNTRY,

2014–2021 (USD MILLION) 72

TABLE 25 GLOBAL OTHER ELECTRICAL STIMULATORS MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 74

TABLE 26 NORTH AMERICA: OTHER ELECTRICAL STIMULATORS MARKET SIZE,

BY COUNTRY, 2014–2021 (USD MILLION) 74

TABLE 27 GLOBAL ELECTROCEUTICALS MARKET SIZE, BY TYPE OF DEVICE,

2014–2021 (USD MILLION) 77

TABLE 28 GLOBAL IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET SIZE,

BY REGION, 2014–2021 (USD MILLION) 78

TABLE 29 NORTH AMERICA: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET SIZE,

BY COUNTRY, 2014–2021 (USD MILLION) 79

TABLE 30 GLOBAL NON-INVASIVE ELECTROCEUTICAL DEVICES MARKET SIZE,

BY REGION, 2014–2021 (USD MILLION) 80

TABLE 31 NORTH AMERICA: NON-INVASIVE ELECTROCEUTICAL DEVICES MARKET SIZE,

BY COUNTRY, 2014–2021 (USD MILLION) 80

TABLE 32 GLOBAL SPINAL CORD STIMULATORS MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 84

TABLE 33 GLOBAL SPINAL CORD STIMULATORS APPLICATION MARKET SIZE FOR CHRONIC PAIN, BY REGION, 2014–2021 (USD MILLION) 85

TABLE 34 NORTH AMERICA: SPINAL CORD STIMULATORS APPLICATION MARKET SIZE FOR CHRONIC PAIN, BY COUNTRY, 2014–2021 (USD MILLION) 85

TABLE 35 GLOBAL SPINAL CORD STIMULATORS APPLICATION MARKET SIZE FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2014–2021 (USD MILLION) 86

TABLE 36 NORTH AMERICA: SPINAL CORD STIMULATORS APPLICATION MARKET SIZE FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2014–2021 (USD MILLION) 87

TABLE 37 GLOBAL SPINAL CORD STIMULATORS APPLICATION MARKET SIZE FOR ISCHEMIA, BY REGION, 2014–2021 (USD MILLION) 88

TABLE 38 NORTH AMERICA: SPINAL CORD STIMULATORS APPLICATION MARKET SIZE FOR ISCHEMIA, BY COUNTRY, 2014–2021 (USD MILLION) 88

TABLE 39 GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 89

TABLE 40 GLOBAL DEEP BRAIN STIMULATORS APPLICATION MARKET SIZE FOR PARKINSON’S DISEASE, BY REGION, 2014–2021 (USD MILLION) 90

TABLE 41 NORTH AMERICA: DEEP BRAIN STIMULATORS APPLICATION MARKET SIZE FOR PARKINSON’S DISEASE, BY COUNTRY, 2014–2021 (USD MILLION) 91

TABLE 42 GLOBAL DEEP BRAIN STIMULATORS APPLICATION MARKET SIZE FOR TREMORS, BY REGION, 2014–2021 (USD MILLION) 92

TABLE 43 NORTH AMERICA: DEEP BRAIN STIMULATORS APPLICATION MARKET SIZE FOR TREMORS, BY COUNTRY, 2014–2021 (USD MILLION) 92

TABLE 44 GLOBAL DEEP BRAIN STIMULATORS APPLICATION MARKET SIZE FOR DEPRESSION, BY REGION, 2014–2021 (USD MILLION) 93

TABLE 45 NORTH AMERICA: DEEP BRAIN STIMULATORS APPLICATION MARKET SIZE FOR DEPRESSION, BY COUNTRY, 2014–2021 (USD MILLION) 94

TABLE 46 GLOBAL DEEP BRAIN STIMULATORS APPLICATION MARKET SIZE FOR OTHER DEEP BRAIN STIMULATION APPLICATIONS, BY REGION, 2014–2021 (USD MILLION) 95

TABLE 47 NORTH AMERICA: DEEP BRAIN STIMULATORS APPLICATION MARKET SIZE FOR OTHER DEEP BRAIN STIMULATION APPLICATIONS, BY COUNTRY,

2014–2021 (USD MILLION) 96

TABLE 48 GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE,

BY APPLICATION, 2014–2021 (USD MILLION) 96

TABLE 49 GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS APPLICATION MARKET SIZE FOR TREATMENT-RESISTANT DEPRESSION, BY REGION,

2014–2021 (USD MILLION) 97

TABLE 50 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS APPLICATION MARKET SIZE FOR TREATMENT-RESISTANT DEPRESSION,

BY COUNTRY, 2014–2021 (USD MILLION) 98

TABLE 51 GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS APPLICATION MARKET SIZE FOR OTHER TRANSCUTANEOUS ELECTRICAL STIMULATION APPLICATIONS, BY REGION, 2014–2021 (USD MILLION) 99

TABLE 52 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS APPLICATION MARKET SIZE FOR OTHER TRANSCUTANEOUS ELECTRICAL STIMULATION APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 99

TABLE 53 GLOBAL VAGUS NERVE STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 100

TABLE 54 GLOBAL VAGUS NERVE STIMULATORS APPLICATION MARKET SIZE FOR EPILEPSY, BY REGION, 2014–2021 (USD MILLION) 101

TABLE 55 NORTH AMERICA: VAGUS NERVE STIMULATORS APPLICATION MARKET SIZE FOR EPILEPSY, BY COUNTRY, 2014–2021 (USD MILLION) 101

TABLE 56 GLOBAL VAGUS NERVE STIMULATORS APPLICATION MARKET SIZE FOR OTHER VAGUS NERVE STIMULATION APPLICATIONS, BY REGION,

2014–2021 (USD MILLION) 102

TABLE 57 NORTH AMERICA: VAGUS NERVE STIMULATORS APPLICATION MARKET SIZE FOR OTHER VAGUS NERVE STIMULATION APPLICATIONS, BY COUNTRY,

2014–2021 (USD MILLION) 103

TABLE 58 GLOBAL SACRAL NERVE STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 103

TABLE 59 GLOBAL SACRAL NERVE STIMULATORS APPLICATION MARKET SIZE FOR URINARY INCONTINENCE, BY REGION, 2014–2021 (USD MILLION) 104

TABLE 60 NORTH AMERICA: SACRAL NERVE STIMULATORS APPLICATION MARKET SIZE FOR URINARY INCONTINENCE, BY COUNTRY, 2014–2021 (USD MILLION) 105

TABLE 61 GLOBAL SACRAL NERVE STIMULATORS APPLICATION MARKET SIZE FOR FECAL INCONTINENCE, BY REGION, 2014–2021 (USD MILLION) 106

TABLE 62 NORTH AMERICA: SACRAL NERVE STIMULATORS APPLICATION MARKET SIZE FOR FECAL INCONTINENCE, BY COUNTRY, 2014–2021 (USD MILLION) 106

TABLE 63 GLOBAL OTHER ELECTRICAL STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 107

TABLE 64 GLOBAL OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR GASTROPARESIS, BY REGION, 2014–2021 (USD MILLION) 108

TABLE 65 NORTH AMERICA: OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR GASTROPARESIS, BY COUNTRY, 2014–2021 (USD MILLION) 109

TABLE 66 GLOBAL OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR OBESITY, BY REGION, 2014–2021 (USD MILLION) 110

TABLE 67 NORTH AMERICA: OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR OBESITY, BY COUNTRY, 2014–2021 (USD MILLION) 110

TABLE 68 GLOBAL OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR DEPRESSION, BY REGION, 2014–2021 (USD MILLION) 111

TABLE 69 NORTH AMERICA: OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR DEPRESSION, BY COUNTRY, 2014–2021 (USD MILLION) 112

TABLE 70 GLOBAL OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR MIGRAINE, BY REGION, 2014–2021 (USD MILLION) 113

TABLE 71 NORTH AMERICA: OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR MIGRAINE, BY COUNTRY, 2014–2021 (USD MILLION) 113

TABLE 72 GLOBAL OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR SPINAL CORD INJURY, BY REGION, 2014–2021 (USD MILLION) 114

TABLE 73 NORTH AMERICA: OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR SPINAL CORD INJURY, BY COUNTRY, 2014–2021 (USD MILLION) 115

TABLE 74 GLOBAL ELECTROCEUTICALS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 118

TABLE 75 GLOBAL ELECTROCEUTICALS MARKET SIZE FOR HOSPITALS, BY REGION,

2014–2021 (USD MILLION) 119

TABLE 76 NORTH AMERICA: ELECTROCEUTICALS MARKET SIZE FOR HOSPITALS,

BY COUNTRY, 2014–2021 (USD MILLION) 120

TABLE 77 GLOBAL ELECTROCEUTICALS MARKET SIZE FOR RESEARCH INSTITUTES,

BY REGION, 2014–2021 (USD MILLION) 120

TABLE 78 NORTH AMERICA: ELECTROCEUTICALS MARKET SIZE FOR RESEARCH INSTITUTES, BY COUNTRY, 2014–2021 (USD MILLION) 121

TABLE 79 GLOBAL ELECTROCEUTICALS MARKET SIZE FOR INDIVIDUAL USERS, BY REGION, 2014–2021 (USD MILLION) 122

TABLE 80 NORTH AMERICA: ELECTROCEUTICALS MARKET SIZE FOR INDIVIDUAL USERS,

BY COUNTRY, 2014–2021 (USD MILLION) 123

TABLE 81 GLOBAL ELECTROCEUTICALS MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 125

TABLE 82 NORTH AMERICA: ELECTROCEUTICALS MARKET SIZE, BY COUNTRY,

2014–2021 (USD MILLION) 128

TABLE 83 NORTH AMERICA: ELECTROCEUTICALS MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 128

TABLE 84 NORTH AMERICA: ELECTROCEUTICALS MARKET SIZE, BY TYPE OF DEVICE,

2014–2021 (USD MILLION) 129

TABLE 85 NORTH AMERICA: SPINAL CORD STIMULATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 129

TABLE 86 NORTH AMERICA: DEEP BRAIN STIMULATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 130

TABLE 87 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 130

TABLE 88 NORTH AMERICA: VAGUS NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 131

TABLE 89 NORTH AMERICA: SACRAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 131

TABLE 90 NORTH AMERICA: OTHER ELECTRICAL STIMULATION MARKET SIZE,

BY APPLICATION, 2014–2021 (USD MILLION) 132

TABLE 91 NORTH AMERICA: ELECTROCEUTICALS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 132

TABLE 92 U.S.: ELECTROCEUTICALS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 135

TABLE 93 U.S.: ELECTROCEUTICALS MARKET SIZE, BY TYPE OF DEVICE,

2014–2021 (USD MILLION) 135

TABLE 94 U.S.: SPINAL CORD STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 136

TABLE 95 U.S.: DEEP BRAIN STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 136

TABLE 96 U.S.: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE,

BY APPLICATION, 2014–2021 (USD MILLION) 137

TABLE 97 U.S.: VAGUS NERVE STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 137

TABLE 98 U.S.: SACRAL NERVE STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 137

TABLE 99 U.S.: OTHER ELECTRICAL STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 138

TABLE 100 U.S.: ELECTROCEUTICALS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 138

TABLE 101 CANADA: ELECTROCEUTICALS MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 139

TABLE 102 CANADA: ELECTROCEUTICALS MARKET SIZE, BY TYPE OF DEVICE,

2014–2021 (USD MILLION) 140

TABLE 103 CANADA: SPINAL CORD STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 140

TABLE 104 CANADA: DEEP BRAIN STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 141

TABLE 105 CANADA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE,

BY APPLICATION, 2014–2021 (USD MILLION) 141

TABLE 106 CANADA: VAGUS NERVE STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 142

TABLE 107 CANADA: SACRAL NERVE STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 142

TABLE 108 CANADA: OTHER ELECTRICAL STIMULATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 143

TABLE 109 CANADA: ELECTROCEUTICALS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 143

TABLE 110 EUROPE: ELECTROCEUTICALS MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 147

TABLE 111 EUROPE: ELECTROCEUTICALS MARKET SIZE, BY TYPE OF DEVICE,

2014–2021 (USD MILLION) 148

TABLE 112 EUROPE: SPINAL CORD STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 148

TABLE 113 EUROPE: DEEP BRAIN STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 148

TABLE 114 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE,

BY APPLICATION, 2014–2021 (USD MILLION) 149

TABLE 115 EUROPE: VAGUS NERVE STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 149

TABLE 116 EUROPE: SACRAL NERVE STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 150

TABLE 117 EUROPE: OTHER ELECTRICAL STIMULATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 150

TABLE 118 EUROPE: ELECTROCEUTICALS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 150

TABLE 119 ASIA-PACIFIC: ELECTROCEUTICALS MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 154

TABLE 120 ASIA-PACIFIC: ELECTROCEUTICALS MARKET SIZE, BY TYPE OF DEVICE,

2014–2021 (USD MILLION) 154

TABLE 121 ASIA-PACIFIC: SPINAL CORD STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 155

TABLE 122 ASIA-PACIFIC: DEEP BRAIN STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 155

TABLE 123 ASIA-PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 156

TABLE 124 ASIA-PACIFIC: VAGUS NERVE STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 156

TABLE 125 ASIA-PACIFIC: SACRAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 156

TABLE 126 ASIA-PACIFIC: OTHER ELECTRICAL STIMULATION MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 157

TABLE 127 ASIA-PACIFIC: ELECTROCEUTICALS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 157

TABLE 128 ROW: ELECTROCEUTICALS MARKET SIZE, BY PRODUCT,

2014–2021 (USD MILLION) 160

TABLE 129 ROW: ELECTROCEUTICALS MARKET SIZE, BY TYPE OF DEVICE,

2014–2021 (USD MILLION) 160

TABLE 130 ROW: SPINAL CORD STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 161

TABLE 131 ROW: DEEP BRAIN STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 161

TABLE 132 ROW: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE,

BY APPLICATION, 2014–2021 (USD MILLION) 161

TABLE 133 ROW: VAGUS NERVE STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 162

TABLE 134 ROW: SACRAL NERVE STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 162

TABLE 135 ROW: OTHER ELECTRICAL STIMULATION MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 162

TABLE 136 ROW: ELECTROCEUTICALS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 163

TABLE 137 PRODUCT LAUNCHES, 2013–2016 165

TABLE 138 APPROVALS, 2013–2016 166

TABLE 139 NEW PRODUCT LAUNCHES, 2013–2016 167

TABLE 140 AGREEMENTS, COLLABORATIONS, JOINT VENTURES, AND PARTNERSHIPS,

2013–2016 168

TABLE 141 MARKETING AND PROMOTION ACTIVITIES, 2013–2016 169

TABLE 142 ACQUISITIONS AND MERGERS, 2013–2016 170

TABLE 143 EXPANSIONS, 2013–2016 170

TABLE 144 OTHER STRATEGIES, 2013–2016 171

List Of Figures, Charts and Diagrams
in Electroceuticals/Bioelectric Medicine Market by Product (Pacemakers, Cochlear Implants, Spinal Cord Stimulators), Type of Device (Implantable, Non-Invasive), Application (Arrhythmia, Depression, Migraine), End User (Hospitals) - Global Forecast to 2021 [Report Updated: 06-06-2016]

LIST OF FIGURES


FIGURE 1 GLOBAL ELECTROCEUTICALS/BIOELECTRONIC MEDICINE MARKET SEGMENTATION 21

FIGURE 2 GLOBAL ELECTROCEUTICALS MARKET: RESEARCH METHODOLOGY STEPS 24

FIGURE 3 KEY DATA FROM SECONDARY SOURCES 25

FIGURE 4 BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 27

FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL MARKET 29

FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR CARDIAC PACEMAKERS AND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET 30

FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR COCHLEAR IMPLANTS MARKET 30

FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR RETINAL IMPLANTS MARKET 31

FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR NEUROMODULATION DEVICES MARKET 31

FIGURE 10 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR GLOBAL ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET 32

FIGURE 11 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 32

FIGURE 12 RESEARCH DESIGN 33

FIGURE 13 DATA TRIANGULATION METHODOLOGY 34

FIGURE 14 NON-INVASIVE ELECTROCEUTICAL DEVICES MARKET TO WITNESS HIGH GROWTH RATE FROM 2016 TO 2021 36

FIGURE 15 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS SEGMENT TO COMMAND LARGEST SHARE OF ELECTROCEUTICALS MARKET, BY PRODUCT, IN 2016 37

FIGURE 16 GLOBAL ELECTROCEUTICALS MARKET, BY END USER, 2016–2021 38

FIGURE 17 GEOGRAPHICAL SNAPSHOT OF GLOBAL ELECTROCEUTICALS MARKET, 2016 39

FIGURE 18 SPINAL CORD STIMULATORS MARKET SIZE, BY APPLICATION,

2016 VS. 2021 (USD MILLION) 40

FIGURE 19 REGULATORY APPROVAL FOR NEW AND ADVANCED ELECTROCEUTICALS TO DRIVE MARKET GROWTH 41

FIGURE 20 RETINAL IMPLANTS SEGMENT TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 42

FIGURE 21 NORTH AMERICA EXPECTED TO DOMINATE GLOBAL ELECTROCEUTICALS MARKET IN 2016 43

FIGURE 22 ASIA-PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 44

FIGURE 23 HOSPITALS SEGMENT TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD 45

FIGURE 24 GLOBAL ELECTROCEUTICALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47

FIGURE 25 GLOBAL ELECTROCEUTICALS MARKET, BY PRODUCT 56

FIGURE 26 RETINAL IMPLANTS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 58

FIGURE 27 GLOBAL ELECTROCEUTICALS MARKET SEGMENTATION, BY TYPE OF DEVICE 76

FIGURE 28 NON-INVASIVE ELECTROCEUTICAL DEVICES SEGMENT TO GROW AT HIGHEST CAGR OF 23.3% DURING FORECAST PERIOD 77

FIGURE 29 GLOBAL ELECTROCEUTICALS MARKET, BY APPLICATION 82

FIGURE 30 GLOBAL ELECTROCEUTICALS MARKET SEGMENTATION, BY END USER 117

FIGURE 31 INDIVIDUAL USERS SEGMENT TO WITNESS HIGHEST GROWTH RATE IN FORECAST PERIOD 118

FIGURE 32 NORTH AMERICA TO COMMAND LARGEST SHARE OF GLOBAL ELECTROCEUTICALS MARKET IN 2016 126

FIGURE 33 NORTH AMERICAN ELECTROCEUTICALS MARKET SNAPSHOT 127

FIGURE 34 EUROPEAN ELECTROCEUTICALS MARKET SNAPSHOT 144

FIGURE 35 ASIA-PACIFIC ELECTROCEUTICALS MARKET SNAPSHOT 151

FIGURE 36 ROW ELECTROCEUTICALS MARKET SNAPSHOT 158

FIGURE 37 TOP 5 STRATEGIES ADOPTED BY PLAYERS OVER LAST THREE YEARS (2013–2016) 164

FIGURE 38 BATTLE FOR MARKET SHARE: MARKET EXPANSION WAS KEY STRATEGY

(2013–2016) 165

FIGURE 39 ORGANIC AND INORGANIC GROWTH STRATEGIES: INDUSTRY TREND VS. KEY PLAYERS 172

FIGURE 40 ORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2013–2016) 173

FIGURE 41 INORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2013–2016) 174

FIGURE 42 PRODUCT MIX OF KEY PLAYERS IN MARKET 175

FIGURE 43 MEDTRONIC PLC: COMPANY SNAPSHOT 176

FIGURE 44 ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT 180

FIGURE 45 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 183

FIGURE 46 COCHLEAR LIMITED: COMPANY SNAPSHOT 186

FIGURE 47 SONOVA HOLDING AG: COMPANY SNAPSHOT 188

FIGURE 48 LIVANOVA PLC: COMPANY SNAPSHOT 191

FIGURE 49 NEVRO CORP.: COMPANY SNAPSHOT 196

FIGURE 50 SECOND SIGHT MEDICAL PRODUCTS, INC.: COMPANY SNAPSHOT 198

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

51136 | MD 4358

Number of Pages

218

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Electroceuticals/Bioelectric Medicine Market by Product (Pacemakers, Cochlear Implants, Spinal Cord Stimulators), Type of Device (Implantable, Non-Invasive), Application (Arrhythmia, Depression, Migraine), End User (Hospitals) - Global Forecast to 2021
The global electroceuticals/bioelectric medicine market is expected to reach USD 25.20 billion by 20...
06 Jun 2016 by MarketsandMarkets USD $5,650 More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

Electroceuticals/Bioelectric Medicine Market by Product (Pacemakers, Cochlear Implants, Spinal Cord Stimulators), Type of Device (Implantable, Non-Invasive), Application (Arrhythmia, Depression, Migraine), End User (Hospitals) - Global Forecast to 2021 [Report Updated: 06-06-2016] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data